Pipeline

All drug candidates are derived from NuclearPharm’s internal R&D initiatives. Our most advanced, NP-DCM-075, is currently translating from preclinical stages into Phase I clinical trials for the detection of Sentinel Lymph Nodes.

NuclearPharm is actively seeking sponsorship to support the ongoing development and successful clinical introduction of this innovative agent.

Sentinel Lymph Node detection

FAP-Expressing Tumor Imaging and Therapy

Prostate Cancer Imaging and Therapy

Infection vs Inflammation Differentiation

How NuclearPharm Can Help You

Schedule a Consultation

Services

Providing top-quality studies for all your research needs. At NuclearPharm, we strive to provide our clients with the highest quality consultancy, preclinical studies, including protocol set up, radiochemistry studies, in vitro assays and in vivo evaluation.

Protocol Set Up

Radiochemistry Studies

In Vitro Assays

Animal Models

Consultation and Reporting

Oncology Models

PK/PD Studies

Other Custom Studies

Meet Our Core Team

Antonio Shegani

CEO | Co-Founder

Nektarios Pirmettis

Head of R&D | Co-Founder

Afroditi Papasavva

Small animal pharmacology

Christiana Gerontati

Radiochemist

Partners & Clients

Partners & Client Testimonials

NP is an exceptional partner in our drug development process. Their expertise and professionalism surpassed our expectations.

Epaminondas K.

Pharmazac

We are very satisfied with the services provided by NP. Reliable, efficient, and delivered top-quality results.

Charalampos T.

Frederick University

I am extremely impressed with the level of expertise and personalized service provided by NuclearPharm.

Ioannis P.

NCSR “Demokritos”

Our experience working with NuclearPharm was amazing. Their team is knowledgeable, responsive, and went above and beyond.

Karim H. D.

Blue Earth Diagnostics

Our office location

Leof. Andrea Siggrou 196, Athina, 176 71, Greece

Contact us